The bacteriophage community is experiencing a period of renaissance of funding and clinical breakthroughs, with 2023 having been a pivotal year when the UK government injected £210m to tackle global antimicrobial resistance. As the only industry-led platform for phage drug developers, the 6th Bacteriophage Therapy Summit will return to Boston in 2024 to unite 90+ phage experts that will:
Expedite Phage Discovery Through High-Throughput Screening and AI to Enhance Targeting and Specificity
Bridge the Gap of Engineered, Natural, and Hybrid Phage to Expand Flexibility
Navigate Regulatory Pathways of Phage to Ensure Successful Clinical Trials
Broaden Phage's Therapeutic and Delivery Vehicle Potential Beyond AMR
Expedite Phage Discovery Through High-Throughput Screening and AI to Enhance Targeting and Specificity
Bridge the Gap of Engineered, Natural, and Hybrid Phage to Expand Flexibility
Navigate Regulatory Pathways of Phage to Ensure Successful Clinical Trials
Broaden Phage's Therapeutic and Delivery Vehicle Potential Beyond AMR
